Caspofungin Dosing for Candidemia
For candidemia, start caspofungin with a 70 mg loading dose on Day 1, followed by 50 mg daily maintenance dose. 1, 2
Standard Dosing Regimen
The FDA-approved and guideline-recommended dosing is straightforward:
- Loading dose: 70 mg IV on Day 1
- Maintenance dose: 50 mg IV daily starting Day 2
This regimen is supported by both the 2016 IDSA guidelines 1 and FDA labeling 2, demonstrating comparable efficacy to amphotericin B in treating candidemia (72.8% vs 67.0% favorable response rates).
When to Consider Dose Adjustments
Higher Maintenance Doses (70-100 mg daily)
Consider increasing the maintenance dose to 70 mg daily in these specific situations:
- Body weight >80 kg - Standard 50 mg dosing results in suboptimal exposure in heavier patients 3
- ICU patients with hypoalbuminemia - Albumin concentration significantly affects caspofungin clearance; do NOT reduce the dose based on Child-Pugh B classification if driven by hypoalbuminemia alone 4, 3
- Critically ill patients on continuous renal replacement therapy - Standard dosing is insufficient to achieve PK/PD targets 5
- C. parapsilosis or C. glabrata with MIC ≥0.1 mg/L - These species require higher exposures 5, 3
Important Caveats
Do not reduce the dose to 35 mg in ICU patients with Child-Pugh B if the classification is driven by hypoalbuminemia rather than true cirrhosis - this results in significantly lower exposure and only 14% target attainment 4. The dose reduction recommendation applies primarily to cirrhotic patients, not critically ill patients with low albumin from other causes.
Duration of Therapy
Continue treatment for 2 weeks after documented clearance of Candida from bloodstream and resolution of clinical signs 1. Remove central venous catheters as early as safely possible 6.
Therapeutic Drug Monitoring
Where available, consider therapeutic drug monitoring targeting a trough concentration (Cmin) >1 mg/L 6, particularly in:
- Critically ill patients with altered volume of distribution
- Patients with severe hypoalbuminemia
- Morbidly obese patients
- Treatment failure scenarios
The AUC24/MIC ratio is the optimal PK/PD parameter, with targets varying by species but generally requiring ratios >10-50 for adequate efficacy 7, 5.